免責聲明: 本站彙整 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公開資料,僅供一般參考,不構成醫療建議、診斷、治療建議或投資建議。

臨床試驗

Bilateral Nucleus Accumbens Focused Ultrasound Neuromodulation for Stimulant Use Disorder

NCT:NCT06474026 · RECRUITING

NCT IDNCT06474026
狀態RECRUITING
開始日期2024-07-01
完成時間2027-07-31
SponsorKorea University Anam Hospital (OTHER)
First posted
Last updated

簡要摘要

The purpose of this clinical trial is to evaluate the initial safety and efficacy of the ExAblate Model 4000 Type 2.1 surgical device for nucleus accumbens (NAc) neuromodulation in patients with psychostimulant use disorder (PUD).

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。

↑